Bayesian network analysis of drug treatment strategies for thyroid associated ophthalmopathy.

Background: The first line treatment for moderate to severe active thyroid associated ophthalmopathy is glucocorticoid pulse therapy, but for patients with contraindications to hormone therapy or hormone resistance, it is urgent to find a suitable treatment plan.

Aims: To find a reliable alternative to hormone pulse therapy for thyroid associated ophthalmopathy by comparing the efficacy with first-line treatment regimens.

Methods: Search PubMed, Ovid, Web of science, Cochrane library, and Clinical Trials.